| Cytomegalovirus coinfection is associated with an increased risk of severe non–AIDS-defining events in a large cohort of HIV-infected patients M Lichtner, P Cicconi, S Vita, A Cozzi-Lepri, M Galli, S Lo Caputo, ... The Journal of infectious diseases 211 (2), 178-186, 2015 | 184 | 2015 |
| European recommendations for the clinical use of HIV drug resistance testing: 2011 update AM Vandamme, RJ Camacho, F Ceccherini-Silberstein, A De Luca, ... Aids Rev 13 (2), 77-108, 2011 | 176 | 2011 |
| Characterization and structural analysis of HIV-1 integrase conservation F Ceccherini-Silberstein, I Malet, R D’Arrigo, A Antinori, AG Marcelin, ... Aids Rev 11 (1), 17-29, 2009 | 171 | 2009 |
| Hepatitis C virus drug resistance associated substitutions and their clinical relevance: Update 2018 MC Sorbo, V Cento, VC Di Maio, AYM Howe, F Garcia, CF Perno, ... Drug Resistance Updates 37, 17-39, 2018 | 170 | 2018 |
| 2019 update of the drug resistance mutations in HIV-1 AM Wensing, V Calvez, F Ceccherini-Silberstein, C Charpentier, ... Topics in antiviral medicine 27 (3), 111, 2019 | 168 | 2019 |
| Functional characterization of substance P receptors on cultured human spinal cord astrocytes: synergism of substance P with cytokines in inducing interleukin‐6 and … C Palma, L Minghetti, M Astolfi, E Ambrosini, F Ceccherini Silberstein, ... Glia 21 (2), 183-193, 1997 | 123 | 1997 |
| Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 … A Cozzi-Lepri, M Noguera-Julian, F Di Giallonardo, R Schuurman, ... Journal of antimicrobial chemotherapy 70 (3), 930-940, 2015 | 120 | 2015 |
| HCV genotypes are differently prone to the development of resistance to linear and macrocyclic protease inhibitors V Cento, C Mirabelli, R Salpini, S Dimonte, A Artese, G Costa, F Mercurio, ... PloS one 7 (7), e39652, 2012 | 104 | 2012 |
| Involvement of novel human immunodeficiency virus type 1 reverse transcriptase mutations in the regulation of resistance to nucleoside inhibitors V Svicher, T Sing, MM Santoro, F Forbici, F Rodríguez-Barrios, A Bertoli, ... Journal of virology 80 (14), 7186-7198, 2006 | 97 | 2006 |
| Non-AIDS defining cancers in the D: A: D Study-time trends and predictors of survival: a cohort study SW Worm, M Bower, P Reiss, F Bonnet, M Law, G Fätkenheuer, ... BMC infectious diseases 13 (1), 1-15, 2013 | 90 | 2013 |
| Emerging patterns and implications of HIV-1 integrase inhibitor resistance AM Geretti, D Armenia, F Ceccherini-Silberstein Current opinion in infectious diseases 25 (6), 677-686, 2012 | 88 | 2012 |
| Multiclass HCV resistance to direct‐acting antiviral failure in real‐life patients advocates for tailored second‐line therapies VC Di Maio, V Cento, I Lenci, M Aragri, P Rossi, S Barbaliscia, M Melis, ... Liver international 37 (4), 514-528, 2017 | 87 | 2017 |
| Identification of the minimal conserved structure of HIV-1 protease in the presence and absence of drug pressure F Ceccherini-Silberstein, F Erba, F Gago, A Bertoli, F Forbici, ... Aids 18 (12), 11-19, 2004 | 87 | 2004 |
| Novel HBsAg markers tightly correlate with occult HBV infection and strongly affect HBsAg detection V Svicher, V Cento, M Bernassola, M Neumann-Fraune, F Van Hemert, ... Antiviral research 93 (1), 86-93, 2012 | 84 | 2012 |
| Understanding HIV compartments and reservoirs V Svicher, F Ceccherini-Silberstein, A Antinori, S Aquaro, CF Perno Current HIV/AIDS Reports 11 (2), 186-194, 2014 | 82 | 2014 |
| Diminished rev-mediated stimulation of human immunodeficiency virus type 1 protein synthesis is a hallmark of human astrocytes E Ludwig, FC Silberstein, J van Empel, V Erfle, M Neumann, ... Journal of virology 73 (10), 8279-8289, 1999 | 82 | 1999 |
| New raltegravir resistance pathways induce broad cross-resistance to all currently used integrase inhibitors I Malet, L Gimferrer Arriaga, A Artese, G Costa, L Parrotta, S Alcaro, ... Journal of Antimicrobial Chemotherapy 69 (8), 2118-2122, 2014 | 81 | 2014 |
| Characterization and structural analysis of novel mutations in human immunodeficiency virus type 1 reverse transcriptase involved in the regulation of resistance to … F Ceccherini-Silberstein, V Svicher, T Sing, A Artese, MM Santoro, ... Journal of virology 81 (20), 11507-11519, 2007 | 80 | 2007 |
| Integrase inhibitor (INI) genotypic resistance in treatment-naive and raltegravir-experienced patients infected with diverse HIV-1 clades T Doyle, DT Dunn, F Ceccherini-Silberstein, C De Mendoza, F Garcia, ... Journal of Antimicrobial Chemotherapy 70 (11), 3080-3086, 2015 | 79 | 2015 |
| Upregulated expression of interleukin-8, RANTES and chemokine receptors in human astrocytic cells infected with HIV-1 M Cota, A Kleinschmidt, F Ceccherini-Silberstein, F Aloisi, M Mengozzi, ... Journal of neurovirology 6 (1), 75-83, 2000 | 78 | 2000 |
